A PHASE II STUDY OF NEOADJUVANT ANTIANGIOGENIC THERAPY COMBINED WITH CAPECITABINE (C) AND RADIOTHERAPY (RT) IN PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER (LARC)

被引:0
|
作者
Torino, F. [4 ]
Cascinu, S. [1 ]
Ciardiello, F. [2 ]
Ballestrero, A. [3 ]
Lencioni, M. [5 ]
Filipelli, G. [6 ]
Martignetti, A.
Granetto, C. [7 ]
Gasparini, G. [8 ]
Frustaci, S. [9 ]
机构
[1] Univ Politecn Delle Marche, Clin Oncol Med, Rome, Italy
[2] Univ Naples Federico 2, Naples, Italy
[3] Univ Genoa, Genoa, Italy
[4] Aco San Filippo Neri, Med Oncol B, Rome, Italy
[5] Osped St Chiara, Pisa, Italy
[6] Osped San Francesco Paola, Paola, Italy
[7] Osped Santa Croce & Carle, Cuneo, Italy
[8] San Filippo Neri Hosp, Div Med Oncol, Rome, Italy
[9] Ctr Riferimento Oncol, I-33081 Aviano, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:142 / 142
页数:1
相关论文
共 50 条
  • [1] Neoadjuvant bevacizumab (BEV) combined with capecitabine (C) and standard radiation therpay (RT) in locally advanced rectal cancer (LARC): A phase II study
    Torino, F.
    Cascinu, S.
    Ciardiello, F.
    Ballestrero, A.
    Lencioni, M.
    Filippelli, G.
    Martignetti, A.
    Granetto, C.
    Sarmiento, R.
    Gasparini, G.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 57 - 57
  • [2] Phase II study of capecitabine and radiotherapy (RT) plus concomitant boost in patients (pts) with locally advanced rectal cancer (LARC).
    Shi, GG
    Lin, E
    Eng, C
    Delcos, M
    Crane, C
    Amos, CB
    Brown, T
    Abbruzzese, JL
    Skibber, J
    Janjan, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 312S - 312S
  • [3] A phase ii study of the combination of bevacizumab plus capecitabine (C) with pre-operative standard radiotherapy (RT) in patients with locally advanced rectal cancer (LARC)
    Torino, F.
    Cascinu, S.
    Ciardiello, F.
    Ballestrero, A.
    Lencioni, R.
    Filippelli, G.
    Crispino, S.
    Granetto, C.
    Calandri, C.
    Sarmiento, R.
    Gasparini, G.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 19 - 19
  • [4] Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer
    Dunst, Juergen
    Debus, Juergen
    Rudat, Volker
    Wulf, Joern
    Budach, Wilfried
    Hoelscher, Tobias
    Reese, Thomas
    Mose, Stephan
    Roedel, Claus
    Zuehlke, Helmut
    Hinke, Axel
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 (09) : 450 - 456
  • [5] A phase II study of capecitabine and concomitant boost radiotherapy (XRT) in patients (pts) with locally advanced rectal cancer (LARC).
    Lin, EH
    Skibber, J
    Delcos, M
    Eng, C
    Christopher, C
    Brown, T
    Vadhan, S
    Hoff, P
    Rodriguez-Bigas, M
    Janjan, NA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 269S - 269S
  • [6] Phase II XERT trial: Neoadjuvant cetuximab, capecitabine and radiotherapy (RT) in locally advanced resectable rectal cancer
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 327 - 327
  • [7] Neoadjuvant cetuximab, capecitabine, and radiotherapy (RT) in locally advanced resectable rectal cancer: results of a phase II trial
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Giampietro Gasparini
    Francesco Torino
    Takayuki Ueno
    Stefano Cascinu
    Teresa Troiani
    Alberto Ballestrero
    Rossana Berardi
    Junichi Shishido
    Akihiko Yoshizawa
    Yukiko Mori
    Satoshi Nagayama
    Paola Morosini
    Masakazu Toi
    [J]. Angiogenesis, 2012, 15 : 141 - 150
  • [9] A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    [J]. EJSO, 2010, 36 (03): : 244 - 250
  • [10] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Gasparini, Giampietro
    Torino, Francesco
    Ueno, Takayuki
    Cascinu, Stefano
    Troiani, Teresa
    Ballestrero, Alberto
    Berardi, Rossana
    Shishido, Junichi
    Yoshizawa, Akihiko
    Mori, Yukiko
    Nagayama, Satoshi
    Morosini, Paola
    Toi, Masakazu
    [J]. ANGIOGENESIS, 2012, 15 (01) : 141 - 150